A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

Abstract

Dosing guidelines for patients with type 1 diabetes using continuous subcutaneous insulin infusion (CSII), which are historically based on clinical experience and retrospective studies of patients consuming an American diet, recommend that basal insulin should represent approximately 50 % of the total daily dose (TDD). Recent prospective studies in the USA and Japan conclude that the more appropriate proportion is closer to 30-40 % of TDD. In addition, currently used formulas for calculating the carbohydrate-to-insulin ratio (CIR) and correction factor (CF) may lead to underdosing of bolus insulin by as much as 12.8-50 % for a hypothetical patient. The discrepancies between traditional formulas and data from newer studies can be accounted for by the more rigorous design of the newer studies (e.g., prospective design, controlled diets, meal omission, and frequent glucose monitoring). International differences in diet composition may also be important to consider when developing dosing recommendations for CSII.

• Authors: Allen B King, Akio Kuroda, Munehide Matsuhisa, Todd Hobbs
• Journal: Current diabetes reports (Curr Diab Rep) Vol. 16 Issue 9 Pg. 83 (09 2016) ISSN: 1539-0829 [Electronic] United States
• PMID: 27457238 (Publication Type: Journal Article, Review)

Chemical References

• Insulin

Topics

• Adult
• Diabetes Mellitus, Type 1 (drug therapy)
• Diet
• Dose-Response Relationship, Drug
• Humans
• Infusions, Subcutaneous
• Insulin (administration & dosage, therapeutic use)
• Insulin Infusion Systems
• Practice Guidelines as Topic